Corrigendum to “integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [ebiomedicine 2 (9) (2015) 1133–1144]

The author wishes to point out that there is an error of author affiliation in this article, whereby author H. Grönberg should be affiliated to “Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden”, and not “Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK”. In the Introduction, first paragraph, “Prostate cancer is the most non-cutaneous common cancer…” should read “Prostate cancer is the most common non-cutaneous cancer…” Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort studyFor the first time in prostate cancer this study demonstrates the importance of integrated genomic analyses incorporating both benign and tumour tissue data in identifying molecular alterations leading to the generation of robust gene sets that are predictive of clinical outcome in independent patient cohorts. Full-Text PDF Open Access